1. A 52-year-old-male patient with metastatic non-small-cell lung cancer and recurrent venous thromboembolism in unusual sites despite anticoagulation. (17th September 2013) Authors: Matikas, Alexios; Vardakis, Nikolaos; Souglakos, John; Georgoulias, Vassilios Journal: BMJ case reports Issue: Volume 2013 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A case of acute myelogenous leukaemia characterised by the BCR-FGFR1 translocation. (20th March 2013) Authors: Matikas, Alexios; Tzannou, Ifigeneia; Oikonomopoulou, Dimitra; Bakiri, Maria Journal: BMJ case reports Issue: Volume 2013 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Beyond CTLA-4: novel immunotherapy strategies for metastatic melanoma. (March 2015) Authors: Matikas, Alexios; Mavroudis, Dimitrios Journal: Future oncology Issue: Volume 11:Number 6(2015) Page Start: 997 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Beyond CTLA-4: novel immunotherapy strategies for metastatic melanoma. (March 2015) Authors: Matikas, Alexios; Mavroudis, Dimitrios Journal: Future oncology Issue: Volume 11:Number 6(2015) Page Start: 997 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Beyond CTLA-4: novel immunotherapy strategies for metastatic melanoma. (March 2015) Authors: Matikas, Alexios; Mavroudis, Dimitrios Journal: Future oncology Issue: Volume 11:Number 6(2015) Page Start: 997 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis. (September 2021) Authors: Boman, Caroline; Zerdes, Ioannis; Mårtensson, Kira; Bergh, Jonas; Foukakis, Theodoros; Valachis, Antonios; Matikas, Alexios Journal: Cancer treatment reviews Issue: Volume 99(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of concepts. (2nd September 2017) Authors: Matikas, Alexios; Foukakis, Theodoros; Bergh, Jonas Journal: Acta oncologica Issue: Volume 56:Number 9(2017) Page Start: 1143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer. (2nd September 2018) Authors: Matikas, Alexios; Lövrot, John; Ramberg, Anna; Eriksson, Margareta; Lindsten, Therese; Lekberg, Tobias; Hedenfalk, Ingrid; Loman, Niklas; Bergh, Jonas; Hatschek, Thomas; Erlandsson, Ann; Foukakis, Theodoros Journal: Oncoimmunology Issue: Volume 7:Number 9(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of cyclin dependent kinases 4/6 inhibitors in the treatment of metastatic breast cancer: a real-world experience. (1st November 2020) Authors: Edman Kessler, Luisa; Wiklander, Oscar; Hamberg, Eva; Bergh, Jonas; Foukakis, Theodoros; Matikas, Alexios Journal: Acta oncologica Issue: Volume 59:Number 11(2020) Page Start: 1382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of cyclin dependent kinases 4/6 inhibitors in the treatment of metastatic breast cancer: a real-world experience. (1st November 2020) Authors: Edman Kessler, Luisa; Wiklander, Oscar; Hamberg, Eva; Bergh, Jonas; Foukakis, Theodoros; Matikas, Alexios Journal: Acta oncologica Issue: Volume 59:Number 11(2020) Page Start: 1382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗